Literature DB >> 25467172

Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals.

Ulises Garza-Ramos1, Humberto Barrios1, Fernando Reyna-Flores1, Elsa Tamayo-Legorreta1, Juan C Catalan-Najera1, Rayo Morfin-Otero2, Eduardo Rodríguez-Noriega2, Patricia Volkow3, Patricia Cornejo-Juarez3, Alejandra González4, Jesus Gaytan-Martinez5, Marisela Del Rocío Gónzalez-Martínez6, Maria Vazquez-Farias6, Jesus Silva-Sanchez7.   

Abstract

The present work describes a prevalence of 36.2% of carbapenemases IMP-, VIM-, and GES-type on 124 imipenem-resistant Pseudomonas aeruginosa clinical isolates. The ESBL GES-19 and carbapenemase GES-20 genes were the most prevalent (84.4%) β-lactamases among imipenem-resistant P. aeruginosa clinical isolates in Mexico. These genes are chromosomal encoded on embedded class 1 integron arrays.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESBL; GES; IMP; Imipenem resistance; VIM

Mesh：

Substances：

Year:  2014        PMID： 25467172     DOI： 10.1016/j.diagmicrobio.2014.09.029

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  14 in total

1.  In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.

Authors:  James A Karlowsky; Krystyna M Kazmierczak; Samuel K Bouchillon; Boudewijn L M de Jonge; Gregory G Stone; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance.

Authors:  Andrea M Hujer; Christopher R Bethel; Magdalena A Taracila; Steven H Marshall; Laura J Rojas; Marisa L Winkler; Ronald E Painter; T Nicholas Domitrovic; Richard R Watkins; Ayman M Abdelhamed; Roshan D'Souza; Andrew R Mack; Richard C White; Thomas Clarke; Derrick E Fouts; Michael R Jacobs; Katherine Young; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

3.  Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa Isolates.

Authors:  Christian M Gill; Tomefa E Asempa; Isabella A Tickler; Caitlin Dela Cruz; Fred C Tenover; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

4.  Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Christian M Gill; Maxwell J Lasko; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 5.  Structural and Functional Aspects of Class A Carbapenemases.

Authors:  Thierry Naas; Laurent Dortet; Bogdan I Iorga
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

6.  Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.

Authors:  Agnieszka E Laudy; Patrycja Róg; Katarzyna Smolińska-Król; Milena Ćmiel; Alicja Słoczyńska; Jan Patzer; Danuta Dzierżanowska; Renata Wolinowska; Bohdan Starościak; Stefan Tyski
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

Review 7.  The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.

Authors:  Dalal Hammoudi Halat; Carole Ayoub Moubareck
Journal:  Antibiotics (Basel)       Date:  2020-04-16

8.  Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United States.

Authors:  Ayesha Khan; Truc T Tran; Rafael Rios; Blake Hanson; William C Shropshire; Zhizeng Sun; Lorena Diaz; An Q Dinh; Audrey Wanger; Luis Ostrosky-Zeichner; Timothy Palzkill; Cesar A Arias; William R Miller
Journal:  Open Forum Infect Dis       Date:  2019-06-06       Impact factor: 3.835

9.  Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.

Authors:  Asma Tchakal-Mesbahi; Merzak Metref; Vijay K Singh; Marianna Almpani; Laurence G Rahme
Journal:  Burns       Date:  2021-03-17       Impact factor: 2.744

10.  High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.

Authors:  Andrés H Uc-Cachón; Carlos Gracida-Osorno; Iván G Luna-Chi; Jonathan G Jiménez-Guillermo; Gloria M Molina-Salinas
Journal:  Medicina (Kaunas)       Date:  2019-09-13       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.